Atlas Trials

A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata

Clinical trial NCT04445363 · UNKNOWN

Trial details

NCT number
NCT04445363
Sponsor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alopecia Areata(AA)
Start date
2020-08-12
Primary completion
2024-12-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.